Incyte (INCY) Gross Profit (2012 - 2026)

Incyte (INCY) posted Gross Profit of $1.2 billion for Q1 2026, down 15.7% on a QoQ basis from $1.4 billion in Q4 2025, and up 19.23% year-over-year from $979.7 million in Q1 2025.

Incyte (INCY) Gross Profit (2012 - 2026) Analysis & Trends

Incyte's Gross Profit history runs 15 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

  • Quarterly Gross Profit rose 19.23% year-over-year to $1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 billion (up 21.24% YoY) and the FY2025 annual result came in at $4.8 billion, up 21.38% from the prior year.
  • Gross Profit was $1.2 billion for Q1 2026 at Incyte, down from $1.4 billion in the prior quarter.
  • Across five years, Gross Profit topped out at $1.4 billion in Q4 2025 and bottomed at $690.6 million in Q1 2022.
  • A 5-year average of $970.3 million and a median of $943.6 million in 2023 frame the typical range for Gross Profit.
  • Peak annual rise in Gross Profit reached 28.92% in 2022, while the deepest fall reached 0.57% in 2022.
  • Incyte's Gross Profit stood at $867.5 million in 2022, then gained by 8.77% to $943.6 million in 2023, then climbed by 15.54% to $1.1 billion in 2024, then increased by 27.1% to $1.4 billion in 2025, then declined by 15.7% to $1.2 billion in 2026.
  • Business Quant data shows INCY's Gross Profit at $1.2 billion in Q1 2026, $1.4 billion in Q4 2025, and $1.3 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Incyte 23.47 Bn 19.46 Bn 1.17 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.17 Bn
Mar 31, 2026 1.17 Bn
Dec 31, 2025 1.39 Bn
Dec 31, 2025 1.39 Bn
Sep 30, 2025 1.27 Bn
Sep 30, 2025 1.27 Bn
Jun 30, 2025 1.14 Bn
Jun 30, 2025 1.14 Bn
Mar 31, 2025 979.71 Mn
Mar 31, 2025 979.71 Mn
Dec 31, 2024 1.09 Bn
Dec 31, 2024 1.09 Bn
Sep 30, 2024 1.05 Bn
Sep 30, 2024 1.05 Bn
Jun 30, 2024 967.13 Mn
Jun 30, 2024 967.13 Mn
Mar 31, 2024 819.93 Mn
Mar 31, 2024 819.93 Mn
Dec 31, 2023 943.59 Mn
Dec 31, 2023 943.59 Mn